Fifth Third Bancorp Acadia Pharmaceuticals Inc Transaction History

Fifth Third Bancorp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$20.84 - $33.47 $9,232 - $14,827	443 New	443 $9,000
Q4 2021 Feb 01, 2022	SELL	$16.79 - $27.09 $18,972 - $30,611	-1,130 Reduced 53.05%	1,000 $23,000
Q1 2021 May 07, 2021	BUY	$25.02 - $54.99 $53,292 - $117,128	2,130 New	2,130 $55,000
Q2 2019 Aug 07, 2019	SELL	$23.32 - $28.12 $88,616 - $106,856	-3,800 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $20,223 - $29,097	-900 Reduced 19.15%	3,800 $85,000
Q2 2017 Aug 11, 2017	BUY	N/A	4,700	4,700 $131,000

316

164M

855K

350K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.72B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.